• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Set To End Week Strong With With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal

    5/10/24 7:16:19 AM ET
    $AKAM
    $BLNK
    $ENB
    $NTNX
    Real Estate
    Real Estate
    Industrial Specialties
    Consumer Discretionary
    Get the next $AKAM alert in real time by email

    U.S. stocks are on track to finish the week on a high, with the index futures pointing to a higher opening on Friday. The recent string of weak data has given raise to hopes that the Federal Reserve may have to relent and take rates lower. A few Federal Reserve speeches scheduled for the day will likely offer some color on what the central bank may do with rates this year.

    A consumer sentiment reading and inflation expectations, which are a part of the report, and tapering earnings news flow could also impact trader sentiment. All eyes will be on the S&P 500 Index to see if the upward momentum is strong enough to lift it past late March closing highs of 5,248.49.

    FuturesPerformance (+/-)
    Nasdaq 100+0.48%
    S&P 500+0.38%
    Dow+0.33%
    R2K+0.36%

    In premarket trading on Friday, the SPDR S&P 500 ETF Trust (NYSE:SPY) rose 0.37% to $522.10, while the Invesco QQQ ETF (NASDAQ:QQQ) gained 0.46% to $443.03, according to Benzinga Pro data.

    Cues From Previous Session:

    Thanks to a spike in jobless claims to the highest since August 2023, the major averages all ended firmly in the green on Thursday. Commenting on the data, fund manager Louis Navellier said, “Overall, since the Fed has an unemployment mandate, rising jobless claims should help to coax the Fed to cut key interest rates sooner than later.”

    The indices opened on a mixed note, but turned uniformly higher in late-morning trading. Subsequently, they stayed firmly in the green before ending the session higher. All S&P sectors, with the exception of IT stocks, gained ground, with energy and real estate stocks seeing standout gains.

    The Dow Jones Industrial Average extended its winning streak to seven, with the Dow, S&P 500 Index and the Russell 2,000 Index now at their highest closing levels in over a month.


    Index

    Performance (+/-)

    Value
    Nasdaq Composite+0.27%16,346.26
    S&P 500 Index+0.51%5,214.08
    Dow Industrials+0.85%39,387.76
    Russell 2000+0.90%2,073.63

    Insights From Analysts:

    Fund Strat’s Tom Lee sees the week’s market performance as positive. While noting that the S&P 500 Index was up 1.7% so far this week on a “light macro” week, the market strategist said, “It's positive that markets drift higher on the absence of data.”

    He also remarked about the outsized gains by small-cap stocks. The iShares Russell 2000 ETF (NYSE:IWM) has added 1.96% this week.

    Fund Strat sees the upcoming April inflation data coming in line and highlighting the possibility that “auto insurance's disproportionate impact on CPI is ebbing.” The firm expects this to push higher the number of Fed cuts for the year, which is positive for stocks. “Bottom line, we are still ‘buy in May.’ The fact that stocks rose this week is a positive signal,” it said.

    Upcoming Economic Data:

    • Fed Governor Michelle Bowman is scheduled to speak at 9 a.m. EDT.
    • The University of Michigan will release its preliminary consumer sentiment index for May at 10 a.m. EDT. Economists expect the index to come in at 76, down from 77.2 in April. The report also has a few inflation expectations readings, which will likely clarify about the forward inflation outlook.
    • Chicago Fed President Austan Goolsbee and Minneapolis Fed President Neel Kashkari are due to speak at 1 p.m. EDT.
    • Fed Vice Chair for Supervision Michael Barr will make a public appearance at 1:30 p.m. EDT.
    • The U.S. Treasury will release its monthly federal budget for April at 2 p.m. EDT, with the balance expected to turn to a surplus of $244.5 billion from a deficit of $235 billion in March.

    See also: Best Futures Trading Software

    Stocks In Focus:

    • Akamai Technologies, Inc. (NASDAQ:AKAM) fell over 10% in premarket trading following the company’s quarterly results announcement.
    • Other stocks moving on earnings are Blink Charging Co. (NASDAQ:BLNK) (over 3.50%), Navitas Semiconductor Corporation (NASDAQ:NVTS) (down about 10.5%), Natera, Inc. (NASDAQ:NTRA) (up over 15%) and Yelp Inc. (NYSE:YELP) (down over 7%).
    • Victoria’s Secret & Co. (NYSE:VSCO) climbed over 6% following the release of its preliminary first-quarter results.
    • Enbridge Inc. (NYSE:ENB) and Novavax, Inc. (NASDAQ:NVAX) are among the notable companies due to release their quarterly results ahead of the market opening.

    Commodities, Bonds, and Global Equity Markets:

    Crude oil futures rose for a third straight session and they were up about 0.72% to a little under $80 a barrel. Meanwhile, gold futures rallied over 1.75% to $2,382.15. The 10-year bond yield, which pulled back on Thursday in the wake of the jobless claims data, traded up 2 basis points to 4.451%.

    The Bitcoin (CRYPTO: BTC) rose over 3% and has topped $35,000.

    The global equity markets were all in the green on Friday, tracking the buoyancy on Wall Street overnight. Asian stocks closed higher, led by the Hong Kong market, although the Malaysian markets ended marginally lower. The major European markets advanced in early trading, with the Euro STOXX 50 Index up 0.80%.

    Read Next: Utilities Notch 7th Straight Session Of Gains: ‘Potential Derivative Play To The AI Boom’

    Photo by Jirapong Manustrong on Shutterstock

    Get the next $AKAM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAM
    $BLNK
    $ENB
    $NTNX

    CompanyDatePrice TargetRatingAnalyst
    Enbridge Inc
    $ENB
    2/17/2026Buy → Hold
    TD Securities
    Enbridge Inc
    $ENB
    2/17/2026Buy → Hold
    Jefferies
    Enbridge Inc
    $ENB
    1/27/2026Overweight → Neutral
    Analyst
    Akamai Technologies Inc.
    $AKAM
    1/16/2026$88.00 → $103.00Neutral
    Citigroup
    Enbridge Inc
    $ENB
    1/16/2026Sector Perform → Sector Outperform
    Scotiabank
    Nutanix Inc.
    $NTNX
    1/15/2026$53.00Overweight → Equal Weight
    Barclays
    Nutanix Inc.
    $NTNX
    1/12/2026Overweight → Equal-Weight
    Morgan Stanley
    Akamai Technologies Inc.
    $AKAM
    1/12/2026$115.00Underweight → Overweight
    Morgan Stanley
    More analyst ratings

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enbridge downgraded by TD Securities

    TD Securities downgraded Enbridge from Buy to Hold

    2/17/26 8:44:18 AM ET
    $ENB
    Natural Gas Distribution
    Energy

    Enbridge downgraded by Jefferies

    Jefferies downgraded Enbridge from Buy to Hold

    2/17/26 8:13:13 AM ET
    $ENB
    Natural Gas Distribution
    Energy

    Enbridge downgraded by Analyst

    Analyst downgraded Enbridge from Overweight to Neutral

    1/27/26 8:40:54 AM ET
    $ENB
    Natural Gas Distribution
    Energy

    $AKAM
    $BLNK
    $ENB
    $NTNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bercovich Michael bought $50,392 worth of shares (65,333 units at $0.77), increasing direct ownership by 53% to 188,563 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:08:54 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    President and CEO Battaglia Michael C. bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 14% to 267,095 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:07:33 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    Director Levine Jack bought $21,525 worth of shares (21,000 units at $1.02) (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    9/8/25 2:49:32 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    $AKAM
    $BLNK
    $ENB
    $NTNX
    SEC Filings

    View All

    SEC Form 10-K filed by Akamai Technologies Inc.

    10-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/20/26 4:14:22 PM ET
    $AKAM
    Real Estate

    Akamai Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/19/26 4:15:50 PM ET
    $AKAM
    Real Estate

    Akamai Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/17/26 4:17:33 PM ET
    $AKAM
    Real Estate

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & General Counsel Ahola Aaron was granted 6,103 shares and covered exercise/tax liability with 1,434 shares (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/23/26 4:10:52 PM ET
    $AKAM
    Real Estate

    Chief Financial Officer Mcgowan Edward J was granted 7,304 shares and covered exercise/tax liability with 676 shares, increasing direct ownership by 26% to 32,163 units (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/23/26 4:10:36 PM ET
    $AKAM
    Real Estate

    EVP, Chief Marketing Officer Salem-Jackson Kim was granted 5,911 shares and covered exercise/tax liability with 2,791 shares, increasing direct ownership by 6% to 53,247 units (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/23/26 4:10:19 PM ET
    $AKAM
    Real Estate

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Akamai Secures Critical Infrastructure with Agentless Zero Trust Segmentation Powered by NVIDIA

    CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akamai (NASDAQ:AKAM) has announced a new solution powered by NVIDIA to protect most vital systems from increasingly sophisticated cyberattacks. By combining Akamai Guardicore Segmentation software with NVIDIA BlueField Data Processing Units (DPU), the companies are delivering a way to support the full operational technology (OT) and industrial control system (ICS) landscape, including "un-agentable" industrial equipment — the heavy machinery and control systems that power modern society. Organizations can implement this hardware-isolated, "agentless" security approach to help align with strict new regulatory requirements and lower their r

    2/23/26 11:00:00 AM ET
    $AKAM
    Real Estate

    Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results

    Fourth quarter highlights Revenue of $1.095 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange*Cloud Infrastructure Services** revenue of $94 million, up 45% year-over-year and up 44% when adjusted for foreign exchange*Security revenue of $592 million, up 11% year-over-year and up 9% when adjusted for foreign exchange*; Guardicore Segmentation and API Security revenue of $90 million, up 36% year-over-year and up 34% when adjusted for foreign exchange*GAAP net income per diluted share of $0.58, down 36% year-over-year and when adjusted for foreign exchange*, and non-GAAP net income per diluted shared* of $1.84, up 11% year-over-year and when adjusted for foreign excha

    2/19/26 4:01:00 PM ET
    $AKAM
    Real Estate

    Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 26, 2026. Details of the event and replay are as follows:Conference call details:Date:February 26, 2026Time:8:30 a.m. ETURL to register phone:Register HereDial-in number:(888) 880-3330 (U.S.) or(+1) (646) 357-8766 (International)Webcast:ir.novavax.com/eventsParticipants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.Participants can als

    2/19/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Leadership Updates

    Live Leadership Updates

    View All

    Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial

    Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today announced the appointment of Kirk Stockwood as Senior Vice President, Commercial. Mr. Stockwood will spearhead Octave's commercial strategy as the company scales operations and expands the reach of its precision neurology platform. Mr. Stockwood brings over 20 years of leadership experience in specialty diagnostics and tools, with a proven track record of commercial scaling within public and private companies. Most recently as Vice President of Sales at Quanterix, he led a global team focused on

    1/8/26 4:01:00 PM ET
    $NTRA
    Medical Specialities
    Health Care

    Victoria's Secret & Co. Reports Third Quarter 2025 Results and Raises Full Year Guidance

    Delivered Net Sales of $1.472 Billion, a 9% Increase Versus Prior Year, Exceeding ExpectationsOperating Results and Earnings Exceed ExpectationsRaises Fiscal Year 2025 Net Sales, Operating Income and Earnings Guidance REYNOLDSBURG, Ohio, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Victoria's Secret & Co. ("VS&Co" or the "Company") (NYSE:VSCO) today reported financial results for the third quarter ended November 1, 2025. Hillary Super, VS&Co Chief Executive Officer, said, "We delivered a standout third quarter, with outperformance on net sales and earnings per share, exceeding the high-end of our guidance. Net sales increased 9% over last year, driven by strength across Victoria's Secret, PINK and

    12/5/25 7:00:00 AM ET
    $VSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Financials

    Live finance-specific insights

    View All

    Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results

    Fourth quarter highlights Revenue of $1.095 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange*Cloud Infrastructure Services** revenue of $94 million, up 45% year-over-year and up 44% when adjusted for foreign exchange*Security revenue of $592 million, up 11% year-over-year and up 9% when adjusted for foreign exchange*; Guardicore Segmentation and API Security revenue of $90 million, up 36% year-over-year and up 34% when adjusted for foreign exchange*GAAP net income per diluted share of $0.58, down 36% year-over-year and when adjusted for foreign exchange*, and non-GAAP net income per diluted shared* of $1.84, up 11% year-over-year and when adjusted for foreign excha

    2/19/26 4:01:00 PM ET
    $AKAM
    Real Estate

    Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 26, 2026. Details of the event and replay are as follows:Conference call details:Date:February 26, 2026Time:8:30 a.m. ETURL to register phone:Register HereDial-in number:(888) 880-3330 (U.S.) or(+1) (646) 357-8766 (International)Webcast:ir.novavax.com/eventsParticipants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.Participants can als

    2/19/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026

    Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2025, after the market closes on Feb. 26, 2026. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET). Earnings Conference Call Information Event: Natera's Fourth Quarter & Full Year 2025 Financial Results Date: February 26, 2026 Time: 1:30 p.m. PT (4:30 p.m. ET) Live Dial-In:   1-888-770-7321 (Domestic) 1-929-201-7107 (International) Conference ID: 7684785 Webcast: https://events.q4inc.com/at

    2/17/26 9:00:00 AM ET
    $NTRA
    Medical Specialities
    Health Care

    $AKAM
    $BLNK
    $ENB
    $NTNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Victorias Secret & Co.

    SC 13G/A - Victoria's Secret & Co. (0001856437) (Subject)

    11/14/24 4:11:11 PM ET
    $VSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Natera Inc.

    SC 13G/A - Natera, Inc. (0001604821) (Subject)

    11/14/24 4:02:50 PM ET
    $NTRA
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Nutanix Inc.

    SC 13G/A - Nutanix, Inc. (0001618732) (Subject)

    11/13/24 3:31:01 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology